Jazz Pharmaceuticals
JAZZ
#2273
Rank
S$8.81 B
Marketcap
$142.71
Share price
-1.78%
Change (1 day)
-20.99%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): S$0.40 B

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings (TTM) are S$0.38 B. In 2023 the company made an earning of S$0.38 B an increase over its 2022 earnings that were of -S$0.49 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.40 B3.63%
2023 S$0.38 B-179.92%
2022 -S$0.49 B230.37%
2021 -S$0.15 B-141.02%
2020 S$0.35 B-39.45%
2019 S$0.59 B-14.2%
2018 S$0.68 B20.03%
2017 S$0.57 B-17.15%
2016 S$0.69 B22.14%
2015 S$0.56 B187.64%
2014 S$0.19 B-50.79%
2013 S$0.40 B73.63%
2012 S$0.23 B41.69%
2011 S$0.16 B116.61%
2010 S$75.27 M262.77%
2009 S$20.74 M-111.33%
2008 -S$0.19 B1.31%
2007 -S$0.19 B77.8%
2006 -S$0.11 B36.59%
2005 -S$74.44 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$3.12 B-904.36%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$2.73 B 605.10%๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.19 B 3,565.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$1.07 B 178.11%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel